News
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
Dr. Sharda Ayurveda has achieved a remarkable approach towards Psoriasis management with Ayurveda. According to Dr. Mukesh Sharda, it is a serious disease that can impact any generation. A sedentary ...
2d
The Healthy @Reader's Digest on MSN4 Types of Toenail Fungus and How To Treat ThemIt can take up to a year for toenail fungus to completely resolve with treatment, and it can come back without proper ...
Among 25 different measures of adiposity, abdominal fat was significantly associated with a risk for psoriasis. Among 25 ...
Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
8d
Zacks Small Cap Research on MSNFBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis…FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...
Gout is a type of inflammatory arthritis characterised by sudden, severe joint pain, often in the big toe, caused by the ...
From sticks to tints to powders to mousses, sunscreen is available in more formats than ever to keep skin safe from the sun.
Our toes can tell us a lot about our health and can give us clues to a range of issues from nutritional deficiencies, to diabetes and circulatory issues, as well as one form of cancer ...
In a smaller subset of subjects having hand/foot psoriasis, the therapy’s treatment demonstrated a numerically higher rate of skin clearance, with 42% achieving a hand and/or foot Physician’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results